YCBD Stock Analysis: Buy, Sell, or Hold?
YCBD - cbdMD, Inc. Common Stock
$0.95
0.08 (8.77%)
▲
5d:
+21.52%
30d:
-18.5%
90d:
+8.05%
BUY
HIGH Confidence
Last Updated: February 3, 2026
Earnings: Feb 12, 2026
8d
Get Alerted When YCBD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called YCBD this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: YCBD shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: YCBD shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: YCBD is currently trading at $0.95, which is considered slightly low relative to its 30-day fair value range of $0.81 to $1.26.
Technical Outlook: Technically, YCBD is showing sideways momentum. Immediate support is located at $0.72, while resistance sits at $1.31. The stock is showing strong short-term momentum, up 8.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+111.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, YCBD is showing sideways momentum. Immediate support is located at $0.72, while resistance sits at $1.31. The stock is showing strong short-term momentum, up 8.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+111.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$0.81 -
$1.26
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.8%)
- BULLISH: Trading 111.6% below Wall St target ($2.00)
Fair Price Analysis
30-Day Fair Range
$0.81 -
$1.26
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.72
Resistance Level
$1.32
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-4.73
Wall Street Target
$2.00
(+111.6%)
Revenue Growth (YoY)
-11.0%
Profit Margin
-8.0%
Last updated: February 03, 2026 5:44 PM ET
Data refreshes hourly during market hours. Next update: 6:44 PM
Data refreshes hourly during market hours. Next update: 6:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is YCBD showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$180 | 65 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$154 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$83 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 57 HOLD |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
11 analysts |
$37 | 59 HOLD |
